Allegiance Lines Up Its Partners
Executive SummaryAs Allegiance prepared for its October IPO they spent some time lining up new business partners. The big news was the signing of Ethicon and Ethicon Endo-Surgery, two powerhouses in key OR categories.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.